Daniel Hill-McManus
University of Sheffield
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Daniel Hill-McManus.
The Lancet | 2014
John Holmes; Yang Meng; Petra Meier; Alan Brennan; Colin Angus; Alexia Campbell-Burton; Yelan Guo; Daniel Hill-McManus; Robin C. Purshouse
Summary Background Several countries are considering a minimum price policy for alcohol, but concerns exist about the potential effects on drinkers with low incomes. We aimed to assess the effect of a £0·45 minimum unit price (1 unit is 8 g/10 mL ethanol) in England across the income and socioeconomic distributions. Methods We used the Sheffield Alcohol Policy Model (SAPM) version 2.6, a causal, deterministic, epidemiological model, to assess effects of a minimum unit price policy. SAPM accounts for alcohol purchasing and consumption preferences for population subgroups including income and socioeconomic groups. Purchasing preferences are regarded as the types and volumes of alcohol beverages, prices paid, and the balance between on-trade (eg, bars) and off-trade (eg, shops). We estimated price elasticities from 9 years of survey data and did sensitivity analyses with alternative elasticities. We assessed effects of the policy on moderate, hazardous, and harmful drinkers, split into three socioeconomic groups (living in routine or manual households, intermediate households, and managerial or professional households). We examined policy effects on alcohol consumption, spending, rates of alcohol-related health harm, and opportunity costs associated with that harm. Rates of harm and costs were estimated for a 10 year period after policy implementation. We adjusted baseline rates of mortality and morbidity to account for differential risk between socioeconomic groups. Findings Overall, a minimum unit price of £0·45 led to an immediate reduction in consumption of 1·6% (−11·7 units per drinker per year) in our model. Moderate drinkers were least affected in terms of consumption (−3·8 units per drinker per year for the lowest income quintile vs 0·8 units increase for the highest income quintile) and spending (increase in spending of £0·04 vs £1·86 per year). The greatest behavioural changes occurred in harmful drinkers (change in consumption of −3·7% or −138·2 units per drinker per year, with a decrease in spending of £4·01), especially in the lowest income quintile (−7·6% or −299·8 units per drinker per year, with a decrease in spending of £34·63) compared with the highest income quintile (−1·0% or −34·3 units, with an increase in spending of £16·35). Estimated health benefits from the policy were also unequally distributed. Individuals in the lowest socioeconomic group (living in routine or manual worker households and comprising 41·7% of the sample population) would accrue 81·8% of reductions in premature deaths and 87·1% of gains in terms of quality-adjusted life-years. Interpretation Irrespective of income, moderate drinkers were little affected by a minimum unit price of £0·45 in our model, with the greatest effects noted for harmful drinkers. Because harmful drinkers on low incomes purchase more alcohol at less than the minimum unit price threshold compared with other groups, they would be affected most by this policy. Large reductions in consumption in this group would however coincide with substantial health gains in terms of morbidity and mortality related to reduced alcohol consumption. Funding UK Medical Research Council and Economic and Social Research Council (grant G1000043).
Journal of Health Economics | 2014
Yang Meng; Alan Brennan; Robin C. Purshouse; Daniel Hill-McManus; Colin Angus; John Holmes; Petra Meier
Highlights • A pseudo-panel approach is used to estimate own- and cross-price elasticities of off- and on-trade alcoholic beverages.• Estimated own-price elasticities are all negative, with off-trade cider and beer being most elastic and off-trade spirits and on-trade ready-to-drinks least elastic.• Estimated cross-price elasticities are smaller in magnitude with a mix of positive and negative signs.• The results could be used for appraising the estimated impact of price-based interventions such as minimum unit pricing and taxation in the UK.
BMJ | 2014
Alan Brennan; Yang Meng; John Holmes; Daniel Hill-McManus; Petra Meier
Objective To evaluate the potential impact of two alcohol control policies under consideration in England: banning below cost selling of alcohol and minimum unit pricing. Design Modelling study using the Sheffield Alcohol Policy Model version 2.5. Setting England 2014-15. Population Adults and young people aged 16 or more, including subgroups of moderate, hazardous, and harmful drinkers. Interventions Policy to ban below cost selling, which means that the selling price to consumers could not be lower than tax payable on the product, compared with policies of minimum unit pricing at £0.40 (€0.57;
Alcohol and Alcoholism | 2013
Petra Meier; Yang Meng; John Holmes; Ben Baumberg; Robin C. Purshouse; Daniel Hill-McManus; Alan Brennan
0.75), 45p, and 50p per unit (7.9 g/10 mL) of pure alcohol. Main outcome measures Changes in mean consumption in terms of units of alcohol, drinkers’ expenditure, and reductions in deaths, illnesses, admissions to hospital, and quality adjusted life years. Results The proportion of the market affected is a key driver of impact, with just 0.7% of all units estimated to be sold below the duty plus value added tax threshold implied by a ban on below cost selling, compared with 23.2% of units for a 45p minimum unit price. Below cost selling is estimated to reduce harmful drinkers’ mean annual consumption by just 0.08%, around 3 units per year, compared with 3.7% or 137 units per year for a 45p minimum unit price (an approximately 45 times greater effect). The ban on below cost selling has a small effect on population health—saving an estimated 14 deaths and 500 admissions to hospital per annum. In contrast, a 45p minimum unit price is estimated to save 624 deaths and 23 700 hospital admissions. Most of the harm reductions (for example, 89% of estimated deaths saved per annum) are estimated to occur in the 5.3% of people who are harmful drinkers. Conclusions The ban on below cost selling, implemented in the England in May 2014, is estimated to have small effects on consumption and health harm. The previously announced policy of a minimum unit price, if set at expected levels between 40p and 50p per unit, is estimated to have an approximately 40-50 times greater effect.
Drug and Alcohol Dependence | 2014
Daniel Hill-McManus; Colin Angus; Yang Meng; John Holmes; Alan Brennan; Petra Meier
AIMS Large discrepancies are typically found between per capita alcohol consumption estimated via survey data compared with sales, excise or production figures. This may lead to significant inaccuracies when calculating levels of alcohol-attributable harms. Using British data, we demonstrate an approach to adjusting survey data to give more accurate estimates of per capita alcohol consumption. METHODS First, sales and survey data are adjusted to account for potential biases (e.g. self-pouring, under-sampled populations) using evidence from external data sources. Secondly, survey and sales data are aligned using different implementations of Rehm et al.s method [in (2010) Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example. Pop Health Metrics 8, 1-12]. Thirdly, the impact of our approaches is tested by using our revised survey dataset to calculate alcohol-attributable fractions (AAFs) for oral and pharyngeal cancers. RESULTS British sales data under-estimate per capita consumption by 8%, primarily due to illicit alcohol. Adjustments to survey data increase per capita consumption estimates by 35%, primarily due to under-sampling of dependent drinkers and under-estimation of home-poured spirits volumes. Before aligning sales and survey data, the revised survey estimate remains 22% lower than the revised sales estimate. Revised AAFs for oral and pharyngeal cancers are substantially larger with our preferred method for aligning data sources, yielding increases in an AAF from the original survey dataset of 0.47-0.60 (males) and 0.28-0.35 (females). CONCLUSION It is possible to use external data sources to adjust survey data to reduce the under-estimation of alcohol consumption and then account for residual under-estimation using a statistical calibration technique. These revisions lead to markedly higher estimated levels of alcohol-attributable harm.
Addiction | 2014
Yang Meng; John Holmes; Daniel Hill-McManus; Alan Brennan; Petra Meier
BACKGROUND In order to successfully address excessive alcohol consumption it is essential to have a means of measuring the drinking patterns of a nation. Owing to the multi-dimensional nature of drinking patterns, usual survey methods have their limitations. The aim of this study was to make use of extremely detailed diary survey data to demonstrate a method of combining different survey measures of drinking in order to reduce these limitations. METHODS Data for 1724 respondents of the 2000/01 National Diet and Nutrition Survey was used to obtain a drinking occasion dataset, by plotting the respondents blood alcohol content over time. Drinking frequency, level and variation measures were chosen to characterise drinking behaviour and usual behaviour was estimated via statistical methods. RESULTS Complex patterns in drinking behaviour were observed amongst population subgroups using the chosen consumption measures. The predicted drinking distribution combines diary data equivalent coverage with a more accurate proportion of non-drinkers. CONCLUSIONS This statistical analysis provides a means of obtaining average consumption measures from diary data and thus reducing the main limitation of this type of data for many applications. We hope that this will facilitate the use of such data in a wide range of applications such as risk modelling, especially for acute harms, and burden of disease studies.
Addiction | 2014
Abdallah K. Ally; Yang Meng; Ratula Chakraborty; Paul W. Dobson; Jonathan S. Seaton; John Holmes; Colin Angus; Yelan Guo; Daniel Hill-McManus; Alan Brennan; Petra Meier
Archive | 2012
Daniel Hill-McManus; Alan Brennan; Tim Stockwell; Norman Giesbrecht; Gerald Thomas; Jinhui Zhao; Gina Martin; Ashley Wettlaufer
Health Technology Assessment | 2016
Eva Kaltenthaler; Christopher Carroll; Daniel Hill-McManus; Alison Scope; Michael Holmes; Stephen Rice; Micah Rose; Paul Tappenden; Nerys Woolacott
British Journal of Clinical Pharmacology | 2018
Daniel Hill-McManus; Elena Soto; Scott Marshall; Steven Lane; Dyfrig A. Hughes